Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2025-02-18 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
FORM 6-K
Foreign Filer Report
2025-02-18 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2025-02-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number'. It details changes in voting rights held by a shareholder ('The Capital Group Companies, Inc.') crossing a notification threshold (Resulting situation: 4.996796%). This specific form (TR-1) is used in the UK/EU regulatory framework to report significant changes in major shareholdings. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2025-02-18 English
ANNUAL FINANCIAL REPORT
Foreign Filer Report
2025-02-18 English
DIRECTORATE CHANGE
Foreign Filer Report
2025-02-18 English
Annual Financial Report
Report Publication Announcement Classification · 1% confidence The document explicitly states: "AstraZeneca PLC (the Company) announced today the publication of its Annual Report and Form 20-F Information 2024 (the Annual Report)." It then details where this report can be accessed (NSM, website) and mentions that it will be dispatched to shareholders. The document itself is an announcement about the release of the Annual Report, not the full report content. Given the short length (3300 chars) and the focus on announcing the publication and providing access details, this fits the definition of a Report Publication Announcement (RPA). Although it mentions the 'Annual Report' (10-K), the nature of this specific filing is the announcement itself.
2025-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.